Common Stock Reserved For Issuance

6 Months Ended

Jun. 30, 2020

Note 9. COMMON STOCK RESERVED FOR ISSUANCE

Common stock has been reserved for the following potential future issuances:

	As of June 30, 2020		As of December 31, 2019
Shares underlying outstanding stock options		836,880		579,731
Shares available for future stock option grants		266,021		230,952
Exchange of Vaccinex Products, LP units		1,169,375		1,173,500
Conversion of VX3 units		1,318,797		1,318,797
Total shares of common stock reserved		3,591,073		3,302,980

During the six months ended June 30, 2020 and 2019, 4,125 and 4,455 units, respectively, of Vaccinex Products, LP were exchanged for shares of the Company’s common stock at par value of $0.0001 per share.